DSP Quant Fund
The scheme seeks to deliver superior returns as compared to the underlying benchmark over the medium to long term through investing in equity and equity related securities. The portfolio of stocks will be selected, weighed and rebalanced based on a quant model theme.
Growthvine rating: 2/5 — ranked #117 of 184 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹20.02 (as of 2026-10-01) |
|---|
| AUM | ₹766 Cr |
|---|
| Expense ratio | 1.31% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Aparna Karnik |
|---|
| Exit load | 0 |
|---|
Performance & risk
| 5-year annualised return | 3.12% |
|---|
| Sharpe ratio | 0.22 |
|---|
| Standard deviation | 14.15% |
|---|
| Max drawdown | −32.69% |
|---|
| Alpha | -3.01 |
|---|
| Beta | 0.88 |
|---|
Over 5 years, captured 47.3% of NIFTY Alpha 50's upside and 56.6% of its downside.
Market cap allocation
| Large cap | 62.3% |
|---|
| Mid cap | 37.6% |
|---|
| Small cap | 0.0% |
|---|
Concentration
| Top 5 holdings | 20.0% |
|---|
| Top 10 holdings | 34.4% |
|---|
| Total holdings | 41 |
|---|
Top holdings
- HDFC Bank Ltd. — 7.5%
- Federal Bank Ltd. — 3.3%
- Hindalco Industries Ltd. — 3.2%
- Larsen & Toubro Limited — 3.0%
- Bajaj Auto Limited — 3.0%
- HCL Technologies Ltd — 3.0%
- Infosys Ltd — 2.9%
- Shriram Finance Limited — 2.9%
- Torrent Pharmaceuticals Ltd. — 2.9%
- Zydus Lifesciences Limited — 2.8%
Top sectors
- Banking & Financial — 17.0%
- Pharma & Biotech — 14.1%
- Automobile — 10.7%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −11.8% | Q4 (Bottom) | #157 of 167 |
| 2025 | 8.1% | Q1 (Top) | #32 of 132 |
| 2024 | 10.0% | Q4 (Bottom) | #81 of 86 |
| 2023 | 19.8% | Q4 (Bottom) | #64 of 66 |
| 2022 | −7.5% | Q4 (Bottom) | #50 of 55 |